| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |